No more disparities among regions in Italy: recent approval of genomic test reimbursability for early breast cancer patients in the country.

Bravaccini, Sara; Mazza, Massimiliano; Maltoni, Roberta

Bravaccini, Sara; Mazza, Massimiliano; Maltoni, Roberta.

Affiliation

Bravaccini S; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014, Meldola, FC, Italy. sara.bravaccini@irst.emr.it.
Mazza M; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014, Meldola, FC, Italy.
Maltoni R; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Via P. Maroncelli 40, 47014, Meldola, FC, Italy.

Breast Cancer Res Treat ; 201(1): 1-3, 2023 Aug.

Article in En | MEDLINE | ID: mdl-37310541

Subject(s)

Breast Neoplasms; Humans; Female; Breast Neoplasms/diagnosis; Breast Neoplasms/genetics; Breast Neoplasms/drug therapy; Gene Expression Profiling; Neoplasm Recurrence, Local/genetics; Genetic Testing; Genomics

Key words

Breast cancer; Genetic testing; Health policy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2023 Document type: Article Affiliation country: Italy Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google